This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0319U only for Clarava™ from Verici Dx Inc. Using a patient blood specimen prior to kidney transplant, the test uses next–generation sequencing (NGS) of specific parts of the transcriptome (mRNA transcribed from DNA) to evaluate gene expression related to immune response. The test uses an algorithmic analysis of the findings to report a score for risk of early acute transplant rejection.
For clinical responsibility, terminology, tips and additional info
start codify free trial.